Get the app!
Back to Trades
Total Value
$510.2K
Net $510.2K sold
Filing Date
Nov 20, 2026
1 transaction
Sales
$510.2K
1 transaction

Trade Summary

On Nov 18, 2026, Stergiou Angelos M., President and CEO, Director, sold $510.2K of SELLAS Life Sciences Group, Inc. (SLS) across 1 transaction. The filing covers Common Stock and reflects net selling of $510.2K. Reported prices ranged from $19.18. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Company Information

Ticker Symbol
SLS
CIK
0001390478

Insider Information

Role
President and CEO, Director
Location
NEW YORK, NY

Filing Details

Filing Date
Nov 20, 2026
Transaction Date
Nov 18, 2026
Accession Number
0001104659-26-130718
Form Type
4
Net Trading Amount
-$510.2K

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Nov 18, 2026Common Stock26,606$19.18Sale$510.2K

Want live alerts when Stergiou Angelos M. trades again?

Download Insider Trades to track SLS, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

Footnotes

  1. (F1)Represents shares sold to satisfy the Reporting Person's tax withholding obligation in connection with the performance based vesting of certain previously granted restricted stock units upon meeting the primary endpoint in the Issuer's Phase 3 REGAL study. These sales are mandated as part of the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

SEC Filing